Clinical Trial: Solidarity/Tokomeza Ebola Trial
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Sudan Ebola Virus Vaccines
Study Type: INTERVENTIONAL
Official Title: A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda
Brief Summary:
The TokomezaPlus Ebola trial is a phase I/II double blind randomised clinical trial designed to assess the safety and immunogenicity of candidate SUDV vaccines in Uganda during the inter outbreak period.Uganda is prone to Ebola virus disease outbreaks especially those caused by the Ebola Sudan (SUDV) species.TokomezaPlus Ebola Vaccine trial protocol has two main components: a) Safety b) Immunogenicity and is designed to create a living protocol that will be used to study the safety and immunogenicity of…
Read more